A pooled analysis of the efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma (mRCC)

被引：0

作者：

Hutson, T. E. ^{[1
]}

Bukowski, R. ^{[2
]}

Rini, B. I. ^{[2
]}

Gore, M. E. ^{[3
]}

Larkin, J. M. ^{[3
]}

Figlin, R. A. ^{[4
]}

Barrios, C. H. ^{[5
]}

Escudier, B. ^{[6
]}

Lin, X. ^{[7
]}

Fly, K. ^{[9
]}

Martell, B. ^{[10
]}

Matczak, E. ^{[10
]}

Motzer, R. J. ^{[8
]}

机构：

[1] Baylor Sammons Canc Ctr Texas Oncol PA, Dallas, TX USA

[2] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[3] Royal Marsden Hosp NHS Trust, London, England

[4] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA

[5] PUCRS Sch Med, Porto Alegre, RS, Brazil

[6] Inst Gustave Roussy, Villejuif, France

[7] Pfizer Oncol, La Jolla, CA USA

[8] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[9] Pfizer Oncol, New London, CT USA

[10] Pfizer Oncol, New York, NY USA

来源：

BJU INTERNATIONAL | 2012年 / 109卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：5 / 6

页数：2

共 50 条

[1] A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC).
Hutson, T. E.
Bukowski, R. M.
Rini, B. I.
Gore, M. E.
Larkin, J. M. G.
Figlin, R. A.
Barrios, C. H.
Escudier, B.
Lin, X.
Fly, K. D.
Martell, B.
Matczak, E.
Motzer, R. J.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[2] Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
T E Hutson
R M Bukowski
B I Rini
M E Gore
J M Larkin
R A Figlin
C H Barrios
B Escudier
X Lin
K Fly
B Martell
E Matczak
R J Motzer
British Journal of Cancer, 2014, 110 : 1125 - 1132
[3] Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
Hutson, T. E.
Bukowski, R. M.
Rini, B. I.
Gore, M. E.
Larkin, J. M.
Figlin, R. A.
Barrios, C. H.
Escudier, B.
Lin, X.
Fly, K.
Martell, B.
Matczak, E.
Motzer, R. J.
BRITISH JOURNAL OF CANCER, 2014, 110 (05) : 1125 - 1132
[4] Sunitinib safety and tolerability in patients with metastatic renal cell carcinoma (MRCC)
Ferrari, A.
Sabbatini, R.
Maur, M.
Giovannelli, S.
Jovic, G.
Conte, P.
ANNALS OF ONCOLOGY, 2006, 17 : XI83 - XI83
[5] Efficacy and safety of everolimus in elderly patients (pts) with metastatic renal cell carcinoma (mRCC)
Osanto, S.
Hutson, T. E.
Calvo, E.
Escudier, B. J.
Oudard, S.
Porta, C.
Bracarda, S.
Grunwald, V.
Ravaud, A.
Motzer, R. J.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[6] SAFETY PROFILE OF SUNITINIB AND SORAFENIB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)
Massari, Francesco
Sperandi, Francesca
Cricca, Antonia
Melotti, Barbara
Martoni, Andrea Angelo
ANNALS OF ONCOLOGY, 2009, 20
[7] Pharmacokinetics (PK) and efficacy of sunitinib in patients with metastatic renal cell carcinoma (mRCC).
Houk, B. E.
Amantea, M.
Motzer, R. J.
Michaelson, M. D.
Rini, B. I.
George, D. J.
Redman, B. G.
Hudes, G. R.
Poland, B.
Bello, C. L.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 224S - 224S
[8] SUNITINIB IN ELDERLY PATIENTS (>=70 YEARS) WITH METASTATIC RENAL CELL CARCINOMA (MRCC): MULTICENTER ANALYSIS OF TOLERABILITY AND EFFICACY
Brunello, A.
Sacco, C.
Barile, C.
Cozzi, M.
Falci, C.
Roma, A.
Scaglione, D.
Jirillo, A.
Monfardini, S.
Basso, U.
ANNALS OF ONCOLOGY, 2008, 19 : 209 - 209
[9] Smoking habit and its impact on the efficacy and safety of sunitinib in metastatic renal cell carcinoma (mRCC) patients
Ruiz, A. L.
Suarez, B.
Llinares, J.
Esteban, E.
EUROPEAN JOURNAL OF CANCER, 2013, 49 : S656 - S657
[10] SUNITINIB AND SORAFENIB THERAPY FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (mRCC): SAFETY PROFILE
Massari, Francesco
Cricca, Antonia
Sperandi, Francesca
Martoni, Andrea Angelo
ANTICANCER RESEARCH, 2010, 30 (04) : 1379 - 1380

← 1 2 3 4 5 →